• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORP GEL - ONE 30MG/3ML PFS; ACID, HYALURONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORP GEL - ONE 30MG/3ML PFS; ACID, HYALURONIC Back to Search Results
Lot Number 0016409G
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Itching Sensation (1943); Swelling (2091); Complaint, Ill-Defined (2331); Reaction (2414)
Event Date 03/07/2017
Event Type  Injury  
Event Description
Pt had an allergic reaction to gel-one.Pt was hospitalized on (b)(6) 2017, pt had swollen eyes, itchy skin, and dry mouth.Pt was taken to er from doctor's office.Dose or amount: 30 mg, frequency: once, route: intra-articularly.Dates of use: (b)(6) 2017.Diagnosis: osteoarthritis.Zimmer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL - ONE 30MG/3ML PFS
Type of Device
ACID, HYALURONIC
Manufacturer (Section D)
SEIKAGAKU CORP
MDR Report Key6394697
MDR Text Key69756420
Report NumberMW5068379
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier87541030091
UDI-Public87541030091
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date11/29/2017
Device Lot Number0016409G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age69 YR
-
-